Prosecution Insights
Last updated: July 17, 2026

Pillsbury Winthrop Shaw Pittman LLP (Cv)

25 pending office actions • 19 clients • 23 examiners • 21 art units • 0 of 25 (0%) have an AI response strategy ready • 46 patents granted in the last 365 days

Quality Metrics (n=1705 apps, methodology: how we score firms)

80.4%
Allowance Rate
n=1705
+0.63σ
Allowance Rate (norm)
n=1705
4.1
OAs to Allowance
n=883
+0.07σ
OAs to Allow (norm)
n=883
1137 days
Time to Allowance
n=883
+14.8pp
Interview Lift
n=1705
30.6%
RCE Rate
n=1705
0.9%
Appeal Rate
n=1705

Rejection Performance (% of received rejections ultimately overcome)

85.4%
§101 Overcome
n=48
85.9%
§102 Overcome
n=192
79.5%
§103 Overcome
n=537
82.9%
§112 Overcome
n=187

Specialization & Scale

A61K, C07K, A61P
Top CPC Subclasses
25%
Top-3 CPC Share
n=1705
0
Practitioners
n=1705
Apps / Practitioner
n=1705 (min 20)

Portfolio Summary

25
Total Pending OAs
12
Non-Final OAs
12
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
6
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (6)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (4%)
14
Medium (56%)
7
Easy (28%)
3
Unknown (12%)

Rejection Statute Mix

BucketCases
§101 only1 (4%)
§103 only12 (48%)
§102 only2 (8%)
§112 only4 (16%)
Double-patenting only3 (12%)
No statute on record3 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
60% of docket
0
Information Tech
0% of docket
1
Communications
4% of docket
1
Semiconductors
4% of docket
7
Mechanical / Eng
28% of docket
1
Business / Other
4% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

250 h
Manual time on pending OAs
50 h
Time saved (low, 20%)
88 h
Time saved (mid, 35%)
2.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NGUYEN, HUONG Q 2 45.8% +44.5%
LAU, MICHAEL J 2 70.8% +24.0%
CODUROGLU, JALAL C 1 85.7% +7.5%
STORMES, JOSEPH FIDELIS 1 86.4% +18.8%
LANKFORD JR, LEON B 1 70.0% +30.9%
ANDERSON, MEGAN M 1 75.0% +27.4%
STEPHENS, AMELIA CAROLE 1 75.0% +50.0%
WALTER, AUDREY BRADLEY 1 81.1% +23.6%
LU, CHENG 1 53.7% +66.2%
SAEED, ALI S 1 31.2% +34.3%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
19069807 Systems and Methods for Efficient Cruise and Hover in VTOL CODUROGLU, JALAL C
18708172 MEMORY ARRAY INCLUDING REPEATER BUFFER STORMES, JOSEPH FIDELIS
17650003 Water Attraction Ride Surface and Methods WALTER, AUDREY BRADLEY

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18249952 NONINVASIVE CARDIOVASCULAR EVENT DETECTION LAU, MICHAEL J 30d overdue

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18249952 NONINVASIVE CARDIOVASCULAR EVENT DETECTION LAU, MICHAEL J 30d overdue
18397180 VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES STEPHENS, AMELIA CAROLE 2d overdue
18190836 SCAFFOLD WOUND DRESSING SAEED, ALI S 14d
19310183 BLOOD SAMPLE OPTIMIZATION DEVICE NGUYEN, HUONG Q 15d
18443780 CARDIAC ARRHYTHMIA TREATMENT DEVICES AND DELIVERY LAU, MICHAEL J 63d
18708172 MEMORY ARRAY INCLUDING REPEATER BUFFER STORMES, JOSEPH FIDELIS
18293313 RNAYLATION LANKFORD JR, LEON B
18402601 METHOD AND DEVICES TO MEASURE PARAMETERS FOR BOXING PUNCHES OR PUSH ACTIONS ANDERSON, MEGAN M

Client Portfolio (19 clients)

Top Art Units

Art UnitApps
37912
37962
16822
28251
16571
37841
16451
37111
16421
16161

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19310183 BLOOD SAMPLE OPTIMIZATION DEVICE Kurin, Inc. NGUYEN, HUONG Q 3791 §112 Final Rejection 15d Pending Aug 26, 2025
19069807 Systems and Methods for Efficient Cruise and Hover in VTOL California Institute Of Technology CODUROGLU, JALAL C DP Non-Final OA Pending Mar 04, 2025
18708172 MEMORY ARRAY INCLUDING REPEATER BUFFER Brillnics Singapore Pte. Ltd. STORMES, JOSEPH FIDELIS 2825 §102 Non-Final OA Pending May 07, 2024
18443780 CARDIAC ARRHYTHMIA TREATMENT DEVICES AND DELIVERY Atacor Medical, Inc. LAU, MICHAEL J 3796 §103 Non-Final OA 63d Pending Feb 16, 2024
18293313 RNAYLATION UNIVERSITAT HEIDELBERG LANKFORD JR, LEON B 1657 §112 Non-Final OA Pending Jan 29, 2024
18402601 METHOD AND DEVICES TO MEASURE PARAMETERS FOR BOXING PUNCHES OR PUSH ACTIONS Activbody Inc. ANDERSON, MEGAN M 3784 §103 Non-Final OA Pending Jan 02, 2024
18397180 VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES The University Of Utah STEPHENS, AMELIA CAROLE 1645 Other Non-Final OA 2d overdue Pending Dec 27, 2023
17650003 Water Attraction Ride Surface and Methods Whitewater West Industries, Ltd. WALTER, AUDREY BRADLEY 3711 §102 Final Rejection Pending Aug 16, 2023
18364409 HLA-J AND MEDICAL/DIAGNOSTIC USES THEREOF Intellexon GmbH LU, CHENG 1642 §112 Non-Final OA Pending Aug 02, 2023
18249952 NONINVASIVE CARDIOVASCULAR EVENT DETECTION UNIVERSITY OF SOUTHERN CALIFORNIA LAU, MICHAEL J 3796 §101 Final Rejection 30d overdue Pending Apr 20, 2023
18190836 SCAFFOLD WOUND DRESSING Sylke, Inc. SAEED, ALI S 1616 §103 Final Rejection 14d Pending Mar 27, 2023
18044028 HUNTINGTIN-RELATED PEPTIDE AGENTS AND USES THEREOF UNIVERSITY OF SOUTHERN CALIFORNIA DABKOWSKI, ERINNE R 1654 §112 Final Rejection Pending Mar 03, 2023
17993759 Systems and Methods for Lead Anchor Insertion Atacor Medical, Inc. TANNER, JOCELIN C 3771 §103 Final Rejection 9d Pending Nov 23, 2022
17999690 SYSTEM, METHOD, DEVICE AND DATA STRUCTURE FOR DIGITAL PIXEL SENSORS Brillnics Singapore Pte. Ltd. PHAM, QUAN L 2637 §103 Final Rejection 15d Pending Nov 22, 2022
18056440 SYSTEMS AND METHODS FOR REAL-TIME CELLULAR DRUG-TARGET ENGAGEMENT Nerd Bio LLC GRAY, JESSICA 1682 §103 Final Rejection Pending Nov 17, 2022
17971477 BAG3 METHODS AND USES FOR TREATMENT OF INFLAMMATION Loyola University Of Chicago HOWARD, ZACHARY C 1674 §103 Non-Final OA 10d overdue Pending Oct 21, 2022
17938209 BAG3 AS A TARGET FOR THERAPY OF HEART FAILURE Temple University Of The Commonwealth System Of Higher Education POLIAKOVA-GEORGAN, EKATERINA 1637 Other Final Rejection 84d overdue Pending Oct 05, 2022
17730118 BLOOD SAMPLE OPTIMIZATION SYSTEM AND BLOOD CONTAMINANT SEQUESTRATION DEVICE AND METHOD Kurin, Inc. NGUYEN, HUONG Q 3791 §103 Non-Final OA Pending Apr 26, 2022
17771793 HLA-H, HLA-J, HLA-L, HLA-V AND HLA-Y AS THERAPEUTIC AND DIAGNOSTIC TARGETS Intellexon GmbH TURPIN, ZACHARY MARK 1682 Other Final Rejection 10d overdue Pending Apr 25, 2022
17435683 COMPOUNDS FOR PREVENTION AND TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION Abrexa Pharmaceuticals, Inc. CREWS, JARET JAMES 1691 §103 Final Rejection 53d overdue Pending Sep 01, 2021
17242755 COMPOUNDS FOR PREVENTION AND TREATMENT OF POST-INTENSIVE CARE COGNITIVE DYSFUNCTION AND COGNITIVE DYSFUNCTION RESULTING FROM RESPIRATORY DISTRESS Abrexa Pharmaceuticals, Inc. RICCI, CRAIG D 1611 DP Non-Final OA Pending Apr 28, 2021
17275084 AUTOMATED GENERATION AND ANALYSIS OF ORGANOIDS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. BATES, KEENAN ALEXANDER 1631 §103 Non-Final OA 13d Pending Mar 10, 2021
17254841 MEANS AND METHODS FOR LYSING BIOLOGICAL CELLS Preomics GmbH BOWERS, NATHAN ANDREW 1799 §103 Non-Final OA 21d Pending Dec 21, 2020
17055075 CRISPR INTERFERENCE BASED HTT ALLELIC SUPPRESSION AND TREATMENT OF HUNTINGTON DISEASE The Children's Hospital of Philadelphia NICOL, ALEXANDER W 1634 §103 Final Rejection 31d overdue Pending Nov 12, 2020
16069778 FACTOR VIII VARIANTS, NUCLEIC ACID SEQUENCES, AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS Giang Nguyen LEE, JIA-HAI 1658 DP Non-Final OA Pending Jul 12, 2018

Managing Pillsbury Winthrop Shaw Pittman LLP (Cv)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month